Related Experiment Video
Updated: Feb 20, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Reactive Oxygen Species in COPD-Related Vascular Remodeling
Li Zuo1, Chia-Chen Chuang2, Alexander D Clark2
1Molecular Physiology and Rehabilitation Research Laboratory, Radiologic Sciences and Respiratory Therapy Division, School of Health and Rehabilitation Sciences, The Ohio State University College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. zuo.4@osu.edu.
Chronic obstructive pulmonary disease (COPD) involves pulmonary vascular remodeling driven by reactive oxygen species (ROS). Treatments targeting ROS may improve lung function and survival in COPD patients.
Area of Science:
- Pulmonary Medicine
- Vascular Biology
- Oxidative Stress
Background:
- Chronic obstructive pulmonary disease (COPD) pathogenesis involves pulmonary vascular alterations.
- Pulmonary vascular remodeling in COPD is linked to inflammation, shear stress, hypoxia, and reactive oxygen species (ROS) overproduction.
- Excessive ROS contributes to endothelial dysfunction and increased inflammatory cell infiltration, worsening COPD severity.
Purpose of the Study:
- To discuss factors contributing to pulmonary vascular remodeling in COPD.
- To emphasize the role of ROS in COPD-related vascular remodeling.
- To explore potential redox-based treatments for COPD.
Main Methods:
- Review of literature on COPD pathogenesis and pulmonary vascular remodeling.
- Analysis of the role of ROS in vascular homeostasis and disease.
- Discussion of current and potential therapeutic interventions.
Main Results:
- Pulmonary vascular remodeling is a key feature of COPD, exacerbated by ROS.
- ROS overproduction impairs vascular function and contributes to pulmonary hypertension in COPD.
- Pulmonary hypertension negatively impacts survival rates in COPD patients.
Conclusions:
- Pulmonary vascular remodeling, driven by ROS, is central to COPD progression and poor outcomes.
- Targeting ROS and vascular dysfunction offers potential therapeutic strategies for COPD.
- Further research into redox treatments is warranted for COPD management.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

